Key words: malignant hypertension; acute renal failure; with papilledema, suggestive of malignant hypertenangiotensin converting enzyme inhibitors; renin sion. A grade 3/6 systolic ejection murmur and coarse crackles were heard on auscultation of the chest. No bruit was audible in the abdomen. The patient was anuric. The urine tested a ++ for
Introduction
protein, and the sediment contained 15 red cells per high-power field. The urea nitrogen was 63 mg/dl and The pathogenesis of acute renal failure in malignant creatinine 5.8 mg/dl. The sodium was 136 mEq/l, pothypertension is incompletely understood. However, the assium 3.2 mEq/l, chloride 95 mEq/l. A specimen of activated renin-angiotensin system appears to be an arterial blood, drawn while the patient was breathing important factor [7] . Since angiotensin II has potent room air, revealed a partial arterial pressure of oxygen vasoconstrictive properties, pharmacological inhibition (PaO 2 ) of 62 mmHg, pH 7.43, partial arterial pressure of angiotensin II production appears rational for the of carbon dioxide (Pa CO 2 ) 41.6 mmHg, and bicarbonate treatment of acute renal failure in patients with malig-27.5 mmol/l. The haematocrit was 35.5%, and the nant hypertension. In fact, a few case reports document white blood cell count was 6200 with a normal differreversal of acute deterioration of renal function in ential. The platelet count was 149 000. Fragmented red malignant hypertension following the treatment with cells were slightly increased to 9% of red blood cells angiotensin converting enzyme inhibitors [2] [3] [4] [5] . Peri-on the blood smear. Coagulation tests revealed pheral blood renin levels in most of these cases were increased fibrinogen/fibrin degradation product (FDP) markedly elevated.
-dimer (9.8 mg/l ) with normal prothrombin time (PT ) We present herein a case of acute renal failure and activated partial thromboplastin time (aPTT ). The secondary to malignant hypertension. Treatment with blood chemistries were within normal range, except angiotensin converting enzyme inhibitors reversed that lactic dehydrogenase (LDH ) was 533 U (normal acute renal failure despite low plasma renin range 100-190 U ) and serum haptoglobin was undeconcentration.
tectable. The urinary osmolality was 343 mOsm/l, and the fractional excretion of sodium was 0.8%. Antinuclear antibody was not detectable, and measurement
Case report
of anti-neutrophil cytoplasmic antibody was not performed. A 47-year-old woman with at least a 5 year history of Endocrinological tests were performed on admission hypertension was referred for the treatment of severe just after one dose of treatment with antihypertensive hypertension on December 28, 1995. She had taken no agents. Plasma renin and aldosterone concentrations regular medication for hypertension, and urinalysis were 8 pg/ml (normal range 10-22 pg/ml ) and had not been performed until admission. She had been 12.9 ng/dl (normal range 4.7-13.1 ng/dl ), respectively. well until 2 days earlier, when she experienced blurred Plasma endothelin-1 concentration was high (3.9 vision, severe headache and nausea. pg/ml; normal range 1.0-2.0 pg/ml ), as measured by On admission, the blood pressure was 234/ radioimmunoassay using endothelin-1-specific anti-176 mmHg, and the pulse rate 59/min and regular. body. Both plasma catecholamines and serum cortisol Fundoscopic findings disclosed exudate retinopathy concentrations were within normal range.
Both kidneys were not atrophic on ultrasonographic 
The clinical course and the results of the serial and aldosterone concentrations were 29 pg/ml and 21.3 ng/dl, respectively. Neither cardiomegaly nor pulmeasurements of plasma renin and aldosterone concentration in the present case are shown in Figure 1 and monary congestion was observed on X-ray of the chest. Table 1 , respectively. One dose of the treatment with nifedipine (20 mg), atenolol (25 mg), and doxazosin Discussion mesilate (1 mg) reduced her blood pressure to 124/96 mmHg resulting in transient loss of her consciousness, and all antihypertensive agents were discon-The low plasma renin concentration in this case is not inconsistent with the diagnosis of malignant hypertentinued. These antihypertensive agents were used only once (data not shown). Hypoxia secondary to pul-sion. Malignant hypertension with very low plasma renin has been previously reported [6, 7] . In addition, monary congestion was improved by haemodialysis therapy, which was started on December 29. On Case et al. [8] have also shown that plasma renin activity was suppressed in two of 10 patients with January 4, the administration of 12.5 mg of captopril daily was started, and the dose was gradually increased malignant hypertension. In this case, plasma renin concentration measured on admission just after one to a maximum of 37.5 mg daily. The blood pressure was maintained~130/80 mmHg. Since eosinophilia dose of treatment with nifedipine, atenolol, and doxazosin mesilate was low, and remained low thereafter. (15% of white blood cell count) developed, 1 mg daily of cilazapril was substituted for captopril on Hypervolaemic state on admission judged by increased central venous pressure and severe cardiomegaly on January 18 (Figure 1 ). Since the administration of cilazapril did not increase plasma renin concentration X-ray of the chest might cause suppressed plasma renin concentration. (6 pg/ml ) despite suppressed plasma aldosterone concentration (4.2 ng/dl ) as shown in Table 1 (indicating It is very interesting that the treatment with cilazapril and temocapril also induced the recovery from acute insufficient suppression of angiotensin converting enzyme activity) 2 mg daily of temocapril was started renal failure in this case with low-renin malignant hypertension. To our knowledge, there is no such a on February 6. The urine volume was gradually increased, and renal dysfunction also gradually reco-previous report. The reason why these angiotensin converting enzyme inhibitors were effective under vered, leading to the discontinuation of haemodialysis therapy. Although plasma renin concentration was not the conditions of low plasma renin concentration is unclear. However, the activated intrarenal elevated during the treatment with captopril, cilazapril alone or cilazapril combined with 2 mg of temocapril, angiotensin II might play an important role in the development of acute renal failure secondary to maligthe treatment with 4 mg of temocapril increased plasma renin concentration to 58 pg/ml on March 14 ( Figure nant hypertension, and the angiotensin converting enzyme inhibitors might induce the recovery from 1, Table 1 ).
Open renal biopsy samples disclosed global sclerosis acute renal failure through the suppression of intrarenal angiotensin II production. Circulating renin levels in eight of 80 glomeruli. The remaining glomeruli revealed ischaemic changes and capillary wall wrinkling may not necessarily reflect local renin-angiotensin system activity [9] . In fact, the findings in this case with mild mesangial expansion. Severe narrowing of the lumina of arterioles was observed. Most small and that hypokalaemia, metabolic alkalosis, and elevated plasma aldosterone concentration relative to overhydrinterlobular arteries exhibited considerable medial hypertrophy without leukocytic infiltration, in addition ation was observed on admission might be suggestive of the activation of angiotensin and aldosterone to markedly layered internal elastic lamina. Immunofluorescence study revealed negative staining system. Endothelin may also play an important role in the for immunoglobulins and complements. On electromicroscopic study, slight subendothelial widening with pathogenesis of acute renal failure secondary to malignant hypertension. In this case, plasma endothelin level amorphous materials as well as partial foot process retraction was observed in some glomeruli. These was markedly elevated. Yoshida et al. [1] have demonstrated extremely high plasma endothelin-1 concentrapathological findings were compatible with malignant hypertension [12] .
tions at the time of admission in three cases of malignant hypertension, and that the plasma level of The patient was discharged on April 1. At that time, 
